Why NRX Pharmaceuticals Stock Is Jumping Today

Shares of NRx Pharmaceuticals (NASDAQ: NRXP) were up by 13.4% as of 11:13 a.m. EST on Thursday. The big gain came after the company announced that it had received a response from the Food and Drug Administration (FDA) related to its Oct. 8 submission of updated manufacturing information for anti-inflammatory drug Zyesami.

NRx Pharmaceuticals stated that the FDA's review allows the company to manufacture Zyesami at commercial scale in batches of between 10,000 and 100,000 doses. The shelf life for the drug was also extended from 62 days to 150 days. 

Image source: Getty Images.

Continue reading

Source Fool.com